FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893221579> ?p ?o ?g. }

• W2893221579 endingPage "81s" @default.
• W2893221579 startingPage "81s" @default.
• W2893221579 abstract "Background: Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver that accounts for an important health problem worldwide. It is the sixth most common cancer worldwide with an incidence of 626,000 new patients a year, and the third most common cause of cancer related death. Secondary or metastatic liver are more common than primary tumor. The most common sites of primary tumor are breast, lung, and colorectal cancer with the majority of secondary liver cancers are metastases from colorectal cancer. Several locoregional catheter-based therapies options are available such as transarterial chemoembolism (TACE), drug eluting bead chemo-embolism and 90 Y radioembolization for treatment of choice for unresectable HCC. Aim: To assess the effectiveness, safety and cost-effectiveness of selective internal radiation therapy (SIRT) using 90 Y microspheres for the treatment of hepatocellular carcinoma. Methods: Electronic databases searched through the Ovid interface using MEDLINE (R) In-Process and Other Non-Indexed Citations and Ovid MEDLINE (R) 1946 to present. Additional articles were identified from reviewing the references of retrieved articles. Last search was conducted on 25th February 2016. Results: Seventeen articles related to SIRT using 90 Y microspheres for HCC were included in this report in term of safety and effectiveness. For primary HCC, limited fair level of retrievable evidence to demonstrate that yttrium-90 radioembolization increased clinical response rates, improve survival and downstaging tumor for resection or transplant in unresectable primary HCC. For liver metastatic disease in colorectal cancer, limited fair level of retrievable evidence to demonstrate improvement in clinical response rates, longer median time to liver progression and overall survival when used in combination with first, second or third line chemotherapy as well as salvage treatment of chemotherapy refractory disease. For liver metastasis in neuroendocrine tumor, limited low level of retrievable evidence to suggest the use of 90 Y radioembolization improved clinical response rates and median overall survival. Sufficient fair level of retrievable to suggest that 90 Y radioembolization is a safe and well-tolerated procedure with some radioembolization specific complications. No retrievable evidence on cost-effectiveness. Conclusion: SIRT using 90 Y microspheres may be used for unresectable primary hepatocellular carcinoma (HCC) and liver metastasis from colorectal cancer (mCRC). Strict criteria should be applied for patient selection and treatment shall be delivered through multidisciplinary team approach. However, SIRT is not recommended for unresectable metastatic liver disease of neuroendocrine tumor (mNET)." @default.
• W2893221579 created "2018-10-05" @default.
• W2893221579 creator A5006936556 @default.
• W2893221579 creator A5028143837 @default.
• W2893221579 creator A5047262127 @default.
• W2893221579 date "2018-10-01" @default.
• W2893221579 modified "2023-09-25" @default.
• W2893221579 title "Selective Internal Radiation Therapy Using Yttrium-90 Radioembolization for Hepatocellular Carcinoma" @default.
• W2893221579 doi "https://doi.org/10.1200/jgo.18.13200" @default.
• W2893221579 hasPublicationYear "2018" @default.
• W2893221579 type Work @default.
• W2893221579 sameAs 2893221579 @default.
• W2893221579 citedByCount "0" @default.
• W2893221579 crossrefType "journal-article" @default.
• W2893221579 hasAuthorship W2893221579A5006936556 @default.
• W2893221579 hasAuthorship W2893221579A5028143837 @default.
• W2893221579 hasAuthorship W2893221579A5047262127 @default.
• W2893221579 hasBestOaLocation W28932215791 @default.
• W2893221579 hasConcept C121608353 @default.
• W2893221579 hasConcept C126322002 @default.
• W2893221579 hasConcept C126838900 @default.
• W2893221579 hasConcept C143998085 @default.
• W2893221579 hasConcept C2776231280 @default.
• W2893221579 hasConcept C2778019345 @default.
• W2893221579 hasConcept C2779185275 @default.
• W2893221579 hasConcept C509974204 @default.
• W2893221579 hasConcept C526805850 @default.
• W2893221579 hasConcept C71924100 @default.
• W2893221579 hasConceptScore W2893221579C121608353 @default.
• W2893221579 hasConceptScore W2893221579C126322002 @default.
• W2893221579 hasConceptScore W2893221579C126838900 @default.
• W2893221579 hasConceptScore W2893221579C143998085 @default.
• W2893221579 hasConceptScore W2893221579C2776231280 @default.
• W2893221579 hasConceptScore W2893221579C2778019345 @default.
• W2893221579 hasConceptScore W2893221579C2779185275 @default.
• W2893221579 hasConceptScore W2893221579C509974204 @default.
• W2893221579 hasConceptScore W2893221579C526805850 @default.
• W2893221579 hasConceptScore W2893221579C71924100 @default.
• W2893221579 hasIssue "Supplement 2" @default.
• W2893221579 hasLocation W28932215791 @default.
• W2893221579 hasOpenAccess W2893221579 @default.
• W2893221579 hasPrimaryLocation W28932215791 @default.
• W2893221579 hasRelatedWork W1999673890 @default.
• W2893221579 hasRelatedWork W2059972987 @default.
• W2893221579 hasRelatedWork W2137214421 @default.
• W2893221579 hasRelatedWork W2137310547 @default.
• W2893221579 hasRelatedWork W2467567502 @default.
• W2893221579 hasRelatedWork W2592028230 @default.
• W2893221579 hasRelatedWork W2752251204 @default.
• W2893221579 hasRelatedWork W2763632826 @default.
• W2893221579 hasRelatedWork W2920323394 @default.
• W2893221579 hasRelatedWork W4311332854 @default.
• W2893221579 hasVolume "4" @default.
• W2893221579 isParatext "false" @default.
• W2893221579 isRetracted "false" @default.
• W2893221579 magId "2893221579" @default.
• W2893221579 workType "article" @default.